Nymox Pharmaceutical
NYMX
#9792
Rank
โ‚ฌ17.36 M
Marketcap
Country
0,19ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -โ‚ฌ2.11 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -โ‚ฌ6.21 Million, an increase over its 2021 earnings that were of -โ‚ฌ11.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ2.11 Million-66.07%
2022 -โ‚ฌ6.21 Million-47.71%
2021 -โ‚ฌ11.88 Million6.61%
2020 -โ‚ฌ11.14 Million-10.91%
2019 -โ‚ฌ12.5 Million24.24%
2018 -โ‚ฌ10.06 Million-20.03%
2017 -โ‚ฌ12.58 Million2.71%
2016 -โ‚ฌ12.25 Million-63.86%
2015 -โ‚ฌ33.9 Million674.44%
2014 -โ‚ฌ4.38 Million-6.11%
2013 -โ‚ฌ4.67 Million-35.66%
2012 -โ‚ฌ7.25 Million-20.76%
2011 -โ‚ฌ9.15 Million38.33%
2010 -โ‚ฌ6.61 Million35.59%
2009 -โ‚ฌ4.88 Million11.8%
2008 -โ‚ฌ4.37 Million-12.94%
2007 -โ‚ฌ5.01 Million8.85%
2006 -โ‚ฌ4.61 Million36.5%
2005 -โ‚ฌ3.38 Million-4.4%
2004 -โ‚ฌ3.53 Million-14.58%
2003 -โ‚ฌ4.13 Million
2001 -โ‚ฌ3.03 Million-20.54%
2000 -โ‚ฌ3.82 Million21.72%
1999 -โ‚ฌ3.14 Million-25.56%
1998 -โ‚ฌ4.21 Million101.3%
1997 -โ‚ฌ2.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ6.44 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.60 B-321,386.44%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.05 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.65 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.49 B-851,326.28%๐Ÿ‡บ๐Ÿ‡ธ USA